Showing 41 - 60 results of 74 for search '"cutaneous oncology"', query time: 0.10s Refine Results
  1. 41
  2. 42

    Sentinel lymph node biopsy for cutaneous melanoma in a real life setting: analysis of 47 cases treated at a private clinic in Brazil by Isabella Parente Almeida, Maria Isabel Ramos Saraiva, Maria Cristina de Lorenzo Messina, João Pereira Duprat, Luiz Guilherme Martins Castro

    Published 2021-12-01
    “…Objective: To present clinical and histologic data, complications and frequency of SLN involvement in CM patients diagnosed and followed at a dermatology/cutaneous oncology PC in São Paulo/Brazil, who were submitted to SLNB. …”
    Get full text
    Article
  3. 43
  4. 44
  5. 45
  6. 46
  7. 47
  8. 48

    Treatment of cutaneous tumors with topical 5% imiquimod cream by Sabrina Sisto Alessi, Jose Antonio Sanches, Walmar Roncalli de Oliveira, Maria Cristina Messina, Eugenio Raul de Almeida Pimentel, Cyro Festa Neto

    Published 2009-01-01
    “…The main objective of our study was to provide data on 89 patients who used a 5% imiquimod cream for the treatment of cutaneous tumors at the Cutaneous Oncology Group of the Dermatology Department of Hospital das Clinicas from 2003 to 2008. …”
    Get full text
    Article
  9. 49
  10. 50

    Radiation therapy techniques in the treatment of skin cancer: an overview of the current status and outlook by Ali Pashazadeh, Axel Boese, Michael Friebe

    Published 2019-11-01
    “…Radiation therapy (RT), with its long successful history in the management of cancer, has shown to be an effective alternative or complementary method in cutaneous oncology. Specifically, for dermatology applications, RT is very often the preferred option due to its favorable cosmetic results, besides the excellent control rate of the tumor. …”
    Get full text
    Article
  11. 51
  12. 52
  13. 53
  14. 54
  15. 55
  16. 56

    Promising Immune Treatment of Advanced Cutaneous Squamous Cell Carcinoma with Cemiplimab—Real-World Experience in the Global SARS-CoV-2 Pandemic by Marta Pabianek, Aleksandra Lesiak, Dariusz Nejc, Łukasz Kuncman, Joanna Narbutt, Małgorzata Skibińska, Magdalena Ciążyńska

    Published 2022-10-01
    “…Immunotherapy with cemiplimab, a recently approved PD1 inhibitor, is an important addition to the cutaneous oncology therapeutic options that may be considered in patients with advanced disease not amenable to surgery or radiotherapy. …”
    Get full text
    Article
  17. 57
  18. 58
  19. 59
  20. 60